NCT03174847View on ClinicalTrials.gov

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

October 20, 2019

Study Completion Date

September 20, 2020

Conditions
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Interventions
PROCEDURE

Adrenalectomy

Adrenalectomy for unilateral adrenal hyperplasia / adenoma

DRUG

Mineralocorticoid Receptor Antagonists

Medical treatment with MRA / amiloride

Trial Locations (1)

529889

Changi General Hospital, Singapore

All Listed Sponsors
lead

Changi General Hospital

OTHER

NCT03174847 - Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism | Biotech Hunter | Biotech Hunter